MIM
MACK

MetLife Investment Management’s Merrimack Pharmaceuticals, Inc. MACK Stock Holding History

MetLife Investment Management’s Portfolio MACK Stock Details MACK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change % 		Capital Flow Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-5,610
Closed -$82.9K – 2966
2024
Q1 		$82.9K Hold
5,610
– – ﹤0.01% 2620
2023
Q4 		$75.2K Hold
5,610
– – ﹤0.01% 2718
2023
Q3 		$69.2K Hold
5,610
– – ﹤0.01% 2767
2023
Q2 		$69K Buy
+5,610
New +$69K ﹤0.01% 2852